Your Article Summary
See Latest ArticlesTreatment combinations targeting apoptosis to improve immunotherapy of melanoma
Cancer Immunology, Immunotherapy, 06/30/09
Hersey P et al. - The signal pathway inhibitors may be effective against these adaptive processes but additional agents that target ER stress pathways are in development. The combination of immunotherapy with agents that target antiapoptotic mechanisms in cancer cells offers a new approach that requires evaluation in clinical trials.
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A Multimarker Prognostic Assay for Primary Cutaneous Melanoma
Clinical Cancer Research, 11/06/09
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study
British Journal of Cancer, 11/03/09
Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508
Cancer, 11/23/09